CASTLE BIOSCIENCES, INC. Proceeds from Debt, Net of Issuance Costs
CASTLE BIOSCIENCES, INC. (CSTL) reported Proceeds from Debt, Net of Issuance Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-02-26
- CASTLE BIOSCIENCES, INC. proceeds from debt, net of issuance costs for the quarter ending 2025-12-31 was $0.00.
- CASTLE BIOSCIENCES, INC. proceeds from debt, net of issuance costs for the quarter ending 2025-09-30 was $0.00.
- CASTLE BIOSCIENCES, INC. proceeds from debt, net of issuance costs for the quarter ending 2025-06-30 was $0.00.
- CASTLE BIOSCIENCES, INC. proceeds from debt, net of issuance costs for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CASTLE BIOSCIENCES, INC. proceeds from debt, net of issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. proceeds from debt, net of issuance costs for fiscal 2024 was $10.00M.
- CASTLE BIOSCIENCES, INC. proceeds from debt, net of issuance costs for fiscal 2023 was $0.00.
- CASTLE BIOSCIENCES, INC. proceeds from debt, net of issuance costs for fiscal 2022 was $0.00.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 9 month as first filed | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $0.00 10-Q · filed 2025-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $10.00M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2025-11-03 | $10.00M 10-Q · filed 2025-11-03 | $10.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $10.00M 10-Q · filed 2025-08-04 | $10.00M derived: sum of 3 quarters · filed 2026-02-26 | $10.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $10.00M 10-Q · filed 2025-05-05 | $10.00M derived: sum of 2 quarters · filed 2026-02-26 | $10.00M derived: sum of 3 quarters · filed 2026-02-26 | $10.00M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $0.00 10-Q · filed 2024-11-04 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $0.00 10-Q · filed 2024-08-05 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | ||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 | ||||
| 2019-09-30 | $9.24M 10-Q · filed 2020-11-09 | $9.24M 10-Q · filed 2019-11-12 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |